MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
AGEN Agenus
- 2.830
- +0.070+2.54%
Close Dec 20 16:00 ET
- 2.830
- 0.0000.00%
Post 20:01 ET
66.82MMarket Cap-0.26P/E (TTM)
2.910High2.660Low790.89KVolume2.750Open2.760Pre Close2.22MTurnover3.40%Turnover RatioLossP/E (Static)23.61MShares19.68852wk High-0.23P/B65.91MFloat Cap2.50052wk Low--Dividend TTM23.29MShs Float8419.554Historical High--Div YieldTTM9.06%Amplitude2.500Historical Low2.812Avg Price1Lot Size
About Agenus Company
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Company Profile
SymbolAGEN
Company NameAgenus
Listing DateFeb 4, 2000
Issue Price18.00
Founded1994
CEODr. Garo H. Armen, PhD
MarketNASDAQ
Employees389
Fiscal Year Ends12-31
Address3 Forbes Road
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421-7305
Phone1-781-674-4400
Websitehttp://www.agenusbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Garo H. Armen, PhD
- Chairman of the Board and Chief Executive Officer
- 5.86M
- Steven J. O'Day
- Chief Medical Officer
- 1.44M
- Christine M. Klaskin
- Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
- 712.75K
- Thomas L. Harrison
- Director
- --
- Dr. Jennifer S. Buell, PhD
- Director
- --
- Brian J. Corvese
- Independent Director
- 888.14K
- Timothy R. Wright
- Lead Independent Director
- 385.50K
- Susan B. Hirsch
- Independent Director
- 242.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.